Home / Research and experimental development on chemicals (except medical and veterinary science)

SMX PTE. LTD.

Live CompanyUEN 201534493GLocal Company

SMX PTE. LTD. is a local company in Singapore with UEN 201534493G. It was registered on 14 Sep 2015, 11 years ago. Its status is Live Company. Its main activity is research and experimental development on chemicals (except medical and veterinary science).

UEN201534493G
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered14 Sep 2015
Main activity (SSIC)72103 Research and experimental development on chemicals (except medical and veterinary science)
Secondary activity46900 Wholesale trade of a variety of goods without a dominant product
Address22 JALAN LEMPENG, #08-03, REGENT PARK, Singapore 128803
64 companies at this address
AreaClementi · District 5 (Pasir Panjang, Hong Leong Garden, Clementi New Town)
Nearest stationClementi MRT, about 436 m
Officers3
Last annual return26 Jul 2025

Newer companies in research and experimental development on chemicals (except medical and veterinary science)

  • ANVL PTE. LTD.202639992Z · 31 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • BAMCORE TECH PTE. LTD.202639601K · 28 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • PMA NANO CARBON TECHNOLOGY PTE. LTD.202616965H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • SILVERX TECHNOLOGY PTE. LTD.202616838H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • INNATUS THERAPEUTICS PTE. LTD.202616249E · 13 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • ABUNDANCE SPECIALTY CHEMICALS PTE. LTD.202611248M · 13 Mar 2026 · Research and experimental development on chemicals (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.